Home LiteratureArticle Details
PMID: 17392344 Published · ppublish English Journal Article Research Support, N.I.H., Intramural Validation Study

Multiplexing siRNAs to compress RNAi-based screen size in human cells.

Nucleic acids research ·Vol. 35 ·No. 8 ·2007-00-00 ·Pages e57

Martin SE, Jones TL, Thomas CL, Lorenzi PL, Nguyen DA, Runfola T, Gunsior M, Weinstein JN, Goldsmith PK, Lader E, Huppi K, Caplen NJ

Abstract

Here we describe a novel strategy using multiplexes of synthetic small interfering RNAs (siRNAs) corresponding to multiple gene targets in order to compress RNA interference (RNAi) screen size. Before investigating the practical use of this strategy, we first characterized the gene-specific RNAi induced by a large subset (258 siRNAs, 129 genes) of the entire siRNA library used in this study ( approximately 800 siRNAs, approximately 400 genes). We next demonstrated that multiplexed siRNAs could silence at least six genes to the same degree as when the genes were targeted individually. The entire library was then used in a screen in which randomly multiplexed siRNAs were assayed for their affect on cell viability. Using this strategy, several gene targets that influenced the viability of a breast cancer cell line were identified. This study suggests that the screening of randomly multiplexed siRNAs may provide an important avenue towards the identification of candidate gene targets for downstream functional analyses and may also be useful for the rapid identification of positive controls for use in novel assay systems. This approach is likely to be especially applicable where assay costs or platform limitations are prohibitive.

MeSH Terms
Cell Line, Tumor Cell Survival Gene Library Humans Oligonucleotide Array Sequence Analysis RNA Interference RNA, Small Interfering/chemical synthesis,chemistry
Chemicals
RNA, Small Interfering
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Martin Scott E
Gene Silencing Section, Office of Science and Technology Partnership, OD, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Jones Tamara L
Thomas Cheryl L
Lorenzi Philip L
Nguyen Dac A
Runfola Timothy
Gunsior Michele
Weinstein John N
Goldsmith Paul K
Lader Eric
Huppi Konrad
Caplen Natasha J
References (34)
34 references, click to expand
  1. Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor.
    Nucleic Acids Res. 2002 Apr 15;30(8):1757-66 PMID: 11937629
  2. Lessons from Nature: microRNA-based shRNA libraries.
    Nat Methods. 2006 Sep;3(9):707-14 PMID: 16929316
  3. Expression profiling reveals off-target gene regulation by RNAi.
    Nat Biotechnol. 2003 Jun;21(6):635-7 PMID: 12754523
  4. Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening.
    Mol Cell. 2003 Sep;12(3):627-37 PMID: 14527409
  5. An approach to genomewide screens of expressed small interfering RNAs in mammalian cells.
    Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):135-40 PMID: 14688408
  6. A resource for large-scale RNA-interference-based screens in mammals.
    Nature. 2004 Mar 25;428(6981):427-31 PMID: 15042091
  7. A large-scale RNAi screen in human cells identifies new components of the p53 pathway.
    Nature. 2004 Mar 25;428(6981):431-7 PMID: 15042092
  8. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia.
    Crit Rev Oncol Hematol. 2004 May;50(2):87-100 PMID: 15157658
  9. Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells.
    Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10715-20 PMID: 15235125
  10. Unlocking the potential of the human genome with RNA interference.
    Nature. 2004 Sep 16;431(7006):371-8 PMID: 15372045
  11. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml.
    Nucleic Acids Res. 1997 Aug 1;25(15):2979-84 PMID: 9224596
  12. An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division.
    Nature. 2004 Dec 23;432(7020):1036-40 PMID: 15616564
  13. Defining and assaying RNAi in mammalian cells.
    Mol Cell. 2005 Jan 7;17(1):1-10 PMID: 15629712
  14. Determining the optimal size of small molecule mixtures for high throughput NMR screening.
    J Biomol NMR. 2005 Mar;31(3):243-58 PMID: 15803397
  15. Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance.
    Nat Cell Biol. 2005 Jun;7(6):591-600 PMID: 15864305
  16. A genetic screen for candidate tumor suppressors identifies REST.
    Cell. 2005 Jun 17;121(6):837-48 PMID: 15960972
  17. A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity.
    Cell. 2005 Jun 17;121(6):849-58 PMID: 15960973
  18. Overview of ribonucleotide reductase inhibitors: an appealing target in anti-tumour therapy.
    Curr Med Chem. 2005;12(11):1283-94 PMID: 15974997
  19. Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis.
    Nature. 2005 Jul 7;436(7047):78-86 PMID: 15889048
  20. siRNA-mediated off-target gene silencing triggered by a 7 nt complementation.
    Nucleic Acids Res. 2005;33(14):4527-35 PMID: 16091630
  21. Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cells.
    Mol Cell. 2005 Dec 9;20(5):673-85 PMID: 16337592
  22. TOR signaling in growth and metabolism.
    Cell. 2006 Feb 10;124(3):471-84 PMID: 16469695
  23. Rho GTPases: promising cellular targets for novel anticancer drugs.
    Curr Cancer Drug Targets. 2006 Feb;6(1):1-14 PMID: 16475973
  24. 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets.
    Nat Methods. 2006 Mar;3(3):199-204 PMID: 16489337
  25. A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase.
    Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3775-80 PMID: 16537454
  26. Targeting polo-like kinase 1 for cancer therapy.
    Nat Rev Cancer. 2006 Apr;6(4):321-30 PMID: 16557283
  27. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen.
    Cell. 2006 Mar 24;124(6):1283-98 PMID: 16564017
  28. A loss-of-function RNA interference screen for molecular targets in cancer.
    Nature. 2006 May 4;441(7089):106-10 PMID: 16572121
  29. Targeting the ERK signaling pathway in cancer therapy.
    Ann Med. 2006;38(3):200-11 PMID: 16720434
  30. Rab3A and Rab27A cooperatively regulate the docking step of dense-core vesicle exocytosis in PC12 cells.
    J Cell Sci. 2006 Jun 1;119(Pt 11):2196-203 PMID: 16684812
  31. Mismatched siRNAs downregulate mRNAs as a function of target site location.
    FEBS Lett. 2006 Jun 26;580(15):3694-8 PMID: 16764866
  32. Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing.
    RNA. 2006 Jul;12(7):1197-205 PMID: 16682562
  33. shRNA libraries and their use in cancer genetics.
    Nat Methods. 2006 Sep;3(9):701-6 PMID: 16929315
  34. Specificity of short interfering RNA determined through gene expression signatures.
    Proc Natl Acad Sci U S A. 2003 May 27;100(11):6347-52 PMID: 12746500
Article Info
Journal
Nucleic acids research
Abbr.
Nucleic Acids Res
ISSN
1362-4962
Published
2007-00-00
Epub
2007-00-28
Pages
e57
Language
English
Region
England
NLM ID
0411011
PMCID
PMC1885663
Subset
IM
Grants
Intramural NIH HHS · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com